
    
      Phase III, multicenter, open label, randomized study of Cisplatin or Carboplatin with
      Gemcitabine versus Gemcitabine alone as adjuvant therapy in patients with resected or ablated
      intra-hepatic cholangiocarcinoma. Subjects will be randomized in a 1:1 fashion to Cisplatin
      or Carboplatin with Gemcitabine versus Gemcitabine alone.
    
  